Risks of Anticoagulation in Patients With Chronic Kidney Disease and Atrial Fibrillation: More Than Just Bleeding?

Research and Practice in Thrombosis and Haemostasis
doi 10.1002/rth2.12188
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Atrial Fibrillation in Patients With Chronic Kidney Disease

Jounal of arrhythmology
2020English

Demystifying the Benefits and Harms of Anticoagulation for Atrial Fibrillation in Chronic Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients With Chronic Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2009English

Exposure to Vitamin K Antagonists and Kidney Function Decline in Patients With Atrial Fibrillation and Chronic Kidney Disease

Research and Practice in Thrombosis and Haemostasis
2019English

MRI Screening for Chronic Anticoagulation in Atrial Fibrillation

Frontiers in Neurology
Neurology
2013English

Risks of Chronic Metabolic Acidosis in Patients With Chronic Kidney Disease

Kidney International
Nephrology
2005English

Chronic Kidney Disease-Induced Atrial Structural Remodeling and Atrial Fibrillation: More Studies on the Pathological Mechanism Are Encouraged

Naunyn-Schmiedeberg's Archives of Pharmacology
MedicinePharmacology
2018English

Anticoagulant Therapy in Patients With Atrial Fibrillation and Concomitant Chronic Kidney Disease: The Results of a Prospective Study

Medical Council
2019English

Anticoagulation in Elderly Patients With Chronic Kidney Disease: How Safe Is It?

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy